Abstract:Background/Objectives: This one-year prospective observational study, conducted at two centers, aimed to report the natural history of retinal sensitivity (RS) loss in diabetic macular ischemia (DMI). Methods: Patients with stable-treated proliferative diabetic retinopathy (PDR) were recruited if there was evidence of DMI on optical coherence tomography angiography, defined as a foveal avascular zone ≥ 0.5 mm2 or parafoveal capillary dropout ≥ 1 quadrant. The minimal visual acuity required for performing microperimetry (MP) was ≥54 Early Treatment Diabetic Retinopathy Study letters (Snellen equivalent 20/80). The overall RS (oRS) and pointwise sensitivity (PWS) within the 3 × 3 mm macula were assessed at baseline and twelve months. A value <25 decibels (dB) was defined as impaired RS, and a decrease of 2 and 7 dB was regarded as mild and severe loss, respectively. Results: A total of 88 patients (97 eyes) were included. No statistically significant MP changes were detected at one year. However, 10% of the cohort lost oRS ≥ 2 dB, and 73% lost ≥2 dB PWS in ≥5 loci, whereas 1% lost oRS ≥ 7 dB, and 4% lost ≥7 dB PWS in ≥5 loci. The foveola and temporal parafovea were the most vulnerable to severe RS loss. Compared to their counterpart, eyes with baseline oRS ≥ 25 dB had significantly more RS loss in the macula and superior parafovea (55% versus 32% and 53% versus 28%, both p = 0.01). Conclusions: Rather than oRS loss, ≥2 dB loss in PWS in ≥5 loci is a more feasible outcome measure for clinical trials in DMI.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the natural change process of retinal sensitivity (RS) within one year in patients with diabetic macular ischemia (DMI). Specifically, the research aims to: 1. **Quantify retinal sensitivity loss**: Evaluate the average change in retinal sensitivity (oRS) of DMI patients within one year, the proportion of severe loss (≥7 dB), and the proportion of mild loss (≥2 dB). 2. **Identify the most vulnerable areas**: Recognize the specific retinal areas that are most likely to experience retinal sensitivity loss within one year. 3. **Evaluate the utility of baseline oRS in predicting future retinal sensitivity loss**: Explore whether oRS ≥25 dB at baseline can be an effective indicator for predicting future retinal sensitivity loss, both globally and locally. ### Methods The study was designed as a one - year prospective observational study, including a total of 88 patients (97 eyes). The main methods include: - **Microperimetry (MP)**: Use a customized 21 - test - point grid (3 × 3 mm area) to evaluate retinal sensitivity. - **Definition of retinal sensitivity**: Overall retinal sensitivity (oRS) is defined as the average of 21 points; point - wise sensitivity (PWS) is defined as the sensitivity of each test point. - **Criteria for retinal sensitivity loss**: oRS < 25 dB is defined as a decrease in retinal sensitivity; a decrease of ≥2 dB is defined as mild loss, and a decrease of ≥7 dB is defined as severe loss. ### Results - **Overall retinal sensitivity change**: From baseline to one year, there was no significant change in overall retinal sensitivity (23.7 ± 4.2 dB to 23.9 ± 3.9 dB, p = 0.33). - **Proportion of retinal sensitivity loss**: - 10% of eyes had an oRS loss of ≥2 dB within one year. - 1% of eyes had an oRS loss of ≥7 dB within one year. - 73% of eyes had a PWS loss of ≥2 dB at at least 5 points. - 4% of eyes had a PWS loss of ≥7 dB at at least 5 points. - **Most vulnerable areas**: The foveola and temporal parafovea are the areas most likely to experience severe retinal sensitivity loss. - **Predictive value of baseline oRS**: Eyes with oRS ≥25 dB at baseline were more likely to experience any degree of retinal sensitivity loss in the following year (55% vs. 32%, p = 0.01), especially in the macular area and superior parafovea. ### Discussion - **Mildness of retinal sensitivity loss**: The retinal sensitivity loss in DMI patients was relatively mild within one year, with no statistically significant change. - **Distribution of retinal sensitivity loss**: The foveola and temporal parafovea are the most vulnerable areas. - **Predictive value of baseline oRS**: oRS ≥25 dB at baseline can be an effective indicator for predicting future retinal sensitivity loss. - **Selection of clinical trial endpoints**: Given the slow progress of retinal sensitivity loss in DMI patients, it is recommended to use an annual average retinal sensitivity loss of ≥2 dB as the endpoint in clinical trials, rather than ≥7 dB, because the latter is relatively rare in DMI. ### Conclusion This study provides an important reference for the future design of clinical trials for DMI, especially in the selection of appropriate endpoints for retinal sensitivity loss. Patients with oRS ≥25 dB at baseline are more likely to experience retinal sensitivity loss in the following year, which provides a basis for early intervention and treatment.

The Natural History of Retinal Sensitivity Loss in Diabetic Macular Ischemia over One Year Evaluated by Microperimetry

Retinal Microstructure Based on Optical Coherence Tomography Predicts Visual Prognosis in Diabetic Macular Edema with Extended Intraretinal Cysts and Subretinal Fluid.

Longitudinal Assessment of Intraretinal Microvascular Abnormalities in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography Angiography

Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema

Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study

Association Of Macular Structure With Microperimetry Sensitivity Following Vitrectomy For Proliferate Diabetic Retinopathy

Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in Non-Proliferative Diabetic Retinopathy

Retinal Photoreceptors and Microvascular Changes in the Assessment of Diabetic Retinopathy Progression: A Two-Year Follow-Up Study

Initial Retinal Nerve Fiber Layer Loss and Risk of Diabetic Retinopathy Over a Four-Year Period

Tracking Macular Sensitivity and Inner Retinal Thickness in Long-Term Type 1 Diabetes: A Five-Year Prospective Examination in Patients without Diabetic Retinopathy

Changes in macular sensitivity in long‐term type 1 diabetic patients without diabetic retinopathy after 5 years of follow‐up

A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment

Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study

Retinal thickness as sensitivity as biomarkers of neurodegeneration in moderate diabetic retinopathy

A Wide Field Swept Source Optical Tomography Angiography Analysis Of The Relationship Between Diabetic Macular Ischemia And Peripheral Perfusion

Parafoveal Microperimetric Retinal Sensitivity as a Key Parameter Associated with Vision Loss in Retinitis Pigmentosa

Re-evaluating diabetic papillopathy using optical coherence tomography and inner retinal sublayer analysis

Non-invasive structural and metabolic retinal markers of disease activity in non-proliferative diabetic retinopathy

Duration of Diabetes as a Risk Factor for Retinal Microvasculature Alterations Detected with Optical Coherence Tomography Angiography in Patients without Clinical Retinopathy

Quantification of vascular and neuronal changes in the peripapillary retinal area secondary to diabetic retinopathy

Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity